Venn Life Sciences Acquires French CRO

August 5, 2014

Applied Clinical Trials

Venn Life Sciences announced the acquisition of Cardinal Systems SAS

Venn Life Sciences, a CRO based in Europe, announced the acquisition of Cardinal Systems SAS, a France based CRO specializing in data management and randomization systems. The acquisition extends Venn’s service offering into those two areas, and strengthens the company’s position as a full-service European CRO.

Read the full release here.